Caplin Point Laboratories LimitedNSE: CAPLIPOINT

Press Release Mar 13 2026

· Issued by Caplin Point Laboratories Limited

Filed with NSE · · 3 pages · English

Release

Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2026, titled "Receipt of final approval by our Subsidiary, Caplin Steriles Limited, from the USFDA for the Potassium Phosphates Injection USP".

Caplin Point Laboratories Limited on 6ix

Earlier from Caplin Point Laboratories

Later from Caplin Point Laboratories

All Caplin Point Laboratories news releases